tirzepatide and opioids CTN-0153: Effects of Semaglutide on Incidence and Outcomes of Stimulant Use Disorders and Opioid Use Disorder in Real-world Populations: Target Trial Emulation Using Patient Electronic Health Records (GLP-SUD) – CTN Benefits of tirzepatide besides weight

One of the most common emotional changes reported with Ozempic is increased anxiety or irritability

Menopause, which typically occurs around age 51, leads to a sharp decline in estrogen, which may affect the metabolism of the thyroid hormone

Medical Notes 8

With roughly 15 million people in the UK living with obesity and only a fraction ever accessing treatment (Novo Nordisk, 2026), removing the injection barrier could genuinely widen reach

This is a critical issue, as a decrease in muscle mass leads to a reduction in basal metabolic rate [41, 42], which could hinder the long-term benefits of obesity treatment by impairing the overall metabolic profile